A Multicenter Randomized Double-Blinded Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease
Study Overview
The purpose of this research study is to investigate the safety and how well inhaled treprostinil works in subjects with pulmonary hypertension (PH) associated with interstitial lung disease (ILD) or combined pulmonary fibrosis and emphysema (CPFE).
Study Description
The purpose of this study is to investigate the safety and how well inhaled treprostinil works in subjects with WHO Group 3 PH.
Additional Information:
Participants will be paid for their participation.
Research Study Identifier: TX6365
ClinicalTrials.gov Identifier: NCT1602009422
Principal Investigator:
William L F Harvey, MD
Currently Recruiting